Morbid obesity is associated with short stature

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 7, 2005, Pages 647-650

  Hermanussen, Michael ^a   Sunder, M ^b   Voigt, M ^c   Tresguerres, J A F ^d  

^a Ludwig Maximilian University ^*  (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Arcuate nucleus; Glutamate; Obesity; Short stature; Voracity

Indexed keywords

GROWTH HORMONE;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; DISEASE ASSOCIATION; FEMALE; GENDER; GERMANY; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; SHORT STATURE;

EID: 23644436877     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.7.647     Document Type: Article

References (19)

1. McLellan F. Obesity rising to alarming levels around the world. Lancet 2002; 359: 1412.
2. Hermanussen M, Danker-Hopfe H, Weber GW. Body weight and the shape of the natural distribution of weight in very large samples of German, Austrian, and Norwegian conscripts. Int J Obesity 2001; 25: 1550-1553.
3. Komlos J, Smith PK, Bogin B. Obesity and the rate of time preference: Is there a connection? J Biosoc Sci 2004; 36: 209-219.
4. Komlos J, Baur M. From the tallest to (one of) the fattest: the enigmatic fate of the American population in the 20th century. Econ Hum Biol 2004; 2: 57-74.
5. Behrman RE Kliegman RM, Arvin AM. Textbook of Pediatrics. Philadelphia, PA: Saunders, 1996; pp 170.
6. Meistas MT, Foster GV, Margolis S, Kowarski AA. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982; 31: 1224-1228.
7. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991; 72: 51-59.
8. Voigt M, Friese K, Pawlowski P, Schneider R, Wenzlaff P, Wermke K. Analyse des Neugeborenenkollektivs der Jahre 1995-1997 der Bundesrepublik Deutschland. Geburtsh Frauenheilk 2001; 61; 700-706.
9. Bourguignon JP. Variations in duration of pubertal growth: a mechanism compensating for differences in timing of puberty and minimizing their effects on final height. Belgian Study Group for Paediatric Endocrinology. Acta Paediatr Scand 1988; Suppl 347: 16-24.
10. Hermanussen M, Tresguerres JAR. Does high glutamate intake cause obesity? J Pediatr Endocrinol Metabol 2003; 16: 965-968.
11. Hermanussen M. Tresguerres JAF. Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis. J Perinat Med 2003; 31: 489-495.
12. Koletzko. Beikostprodukte auf Milchbasis. Pädiat Prax 2002; 62: 386-388.
13. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719-721.
14. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 1969; 166: 386-388.
15. Holzwarth-McBride MA, Sladek JR, Knigge KM. Monosodium glutamate induced lesion of the arcuate nucleus. II Fluorescence histochemistry of catecholamines. Anat Rec 1976; 186: 197-205.
16. Jequier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379-388.
17. Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord 2001; 25 (Suppl 5): S78-82.
18. Lu XY. Role of central melanocortin signaling in eating disorders. Psychopharmacol Bull 2001; 35: 45-65.
19. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.